[Federal Register: October 11, 2006 (Volume 71, Number 196)]
[Notices]
[Page 59756]
[DOCID:fr11oc06-46]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP06-433-001]

CenterPoint Energy Gas Transmission Company; Notice of Compliance
Filing

October 3, 2006.
    Take notice that on September 28, 2006, CenterPoint Energy Gas
Transmission Company (CEGT) tendered for filing as part of its FERC Gas
Tariff, Sixth Revised Volume No. 1, tariff sheets listed below to be
effective September 1, 2006. CEGT states that the purpose of this
filing is to make certain corrections to tariff sheets submitted on
July 12, 2006 to the following tariff sheets:

Substitute Original Sheet No. 729A
Substitute First Revised Sheet No. 734
Substitute First Revised Sheet No. 742
Substitute First Revised Sheet No. 743
Sheet Nos. 765-769
Substitute Original Sheet No. 787A
Sheet Nos. 791-798

    Any person desiring to protest this filing must file in accordance
with Rule 211 of the Commission's Rules of Practice and Procedure (18
CFR 385.211). Protests to this filing will be considered by the
Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Such protests
must be filed in accordance with the provisions of section 154.210 of
the Commission's regulations (18 CFR 154.210). Anyone filing a protest
must serve a copy of that document on all the parties to the
proceeding.
    The Commission encourages electronic submission of protests in lieu
of paper using the ``eFiling'' link at http://www.ferc.gov. Persons

unable to file electronically should submit an original and 14 copies
of the protest to the Federal Energy Regulatory Commission, 888 First
Street, NE., Washington, DC 20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
[FR Doc. E6-16768 Filed 10-10-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 82, Number 57 (Monday, March 27, 2017)]
[Rules and Regulations]
[Pages 15129-15131]
[FR Doc No: 2017-05802]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2015-8128; Airspace Docket No. 15-AEA-14]

Amendment of Class D and Class E Airspace; Elmira, NY

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This action amends Class D and E airspace at Elmira, NY, as
the ERINN Outer Marker (OM) has been decommissioned requiring airspace
reconfiguration at Elmira/Corning Regional Airport. This action
enhances the safety and airspace management of Instrument Flight Rules
(IFR) operations at the airport. This action also updates the
geographic coordinates of the airport, and eliminates the Notice to
Airmen (NOTAM) part-time status of the Class E airspace designated as
an extension to a Class D surface area. Also, the FAA found the Class E
airspace designated as an extension to a class D surface area
description was inaccurate. This action corrects the error.

DATES: Effective 0901 UTC, June 22, 2017. The Director of the Federal
Register approves this incorporation by reference action under title 1,
Code of Federal Regulations, part 51, subject to the annual revision of
FAA Order 7400.11 and publication of conforming amendments.

ADDRESSES: FAA Order 7400.11A, Airspace Designations and Reporting
Points, and subsequent amendments can be viewed on line at http://www.faa.gov/air_traffic/publications/. For further information, you can
contact the Airspace Policy Group, Federal Aviation Administration, 800
Independence Avenue SW.,

Washington, DC, 20591; telephone: 1-800-647-8927, or<PHONE_NUMBER>. The
Order is also available for inspection at the National Archives and
Records Administration (NARA). For information on the availability of
FAA Order 7400.11A at NARA, call<PHONE_NUMBER>, or go to http://www.archives.gov/federal_register/code_of_federal-regulations/ibr_locations.html.
    FAA Order 7400.11, Airspace Designations and Reporting Points, is
published yearly and effective on September 15.

FOR FURTHER INFORMATION CONTACT: John Fornito, Operations Support
Group, Eastern Service Center, Federal Aviation Administration, P.O.
Box 20636, Atlanta, Georgia 30320; telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Authority for This Rulemaking

    The FAA's authority to issue rules regarding aviation safety is
found in Title 49 of the United States Code. Subtitle I, Section 106
describes the authority of the FAA Administrator. Subtitle VII,
Aviation Programs, describes in more detail the scope of the agency's
authority. This rulemaking is promulgated under the authority described
in Subtitle VII, Part, A, Subpart I, Section 40103. Under that section,
the FAA is charged with prescribing regulations to assign the use of
airspace necessary to ensure the safety of aircraft and the efficient
use of airspace. This regulation is within the scope of that authority
as it amends Class D and Class E airspace at Elmira/Corning Regional
Airport, Elmira, NY.

History

    On December 13, 2016, the FAA published in the Federal Register a
notice of proposed rulemaking (NPRM) to amend Class D and Class E
airspace at Elmira, NY. (81 FR 89885) Docket No. FAA-2015-8128. This
proposed change is necessary as the ERINN Outer Marker (OM) has been
decommissioned requiring airspace reconfiguration at Elmira/Corning
Regional Airport. Interested parties were invited to participate in
this rulemaking effort by submitting written comments on the proposal
to the FAA. No comments were received.
    Subsequent to publication, the regulatory text for the Class E
airspace designated as an extension was found to have some inaccuracies
and is rewritten for clarity.
    Class D and Class E airspace designations are published in
paragraphs 5000, 6002 and 6004, respectively, of FAA Order 7400.11A
dated August 3, 2016, and effective September 15, 2016, which is
incorporated by reference in 14 CFR part 71.1. The Class D and Class E
airspace designations listed in this document will be published
subsequently in the Order.

Availability and Summary of Documents for Incorporation by Reference

    This document amends FAA Order 7400.11A, Airspace Designations and
Reporting Points, dated August 3, 2016, and effective September 15,
2016. FAA Order 7400.11A is publicly available as listed in the
ADDRESSES section of this document. FAA Order 7400.11A lists Class A,
B, C, D, and E airspace areas, air traffic service routes, and
reporting points.

The Rule

    This amendment to Title 14, Code of Federal Regulations (14 CFR)
part 71 amends Class D airspace, Class E surface area airspace, and
Class E airspace designated as an extension to a Class D surface area
at Elmira/Corning Regional Airport, Elmira, NY. This action amends the
geographic coordinates of the airport to coincide with the FAA's
aeronautical database, and eliminates the NOTAM information from the
regulatory text of the Class E airspace designated as an extension to
Class D that reads, ``This Class E airspace area is effective during
the specific dates and time established in advance by Notice to Airmen.
The effective date and time will thereafter be continuously published
in the Airport/Facility Directory.'' This action also corrects some
inaccuracies in the segment dimensions northeast, east, and southwest
of the airport in the description of Class E airspace designated as an
extension to a Class D surface.

Regulatory Notices and Analyses

    The FAA has determined that this regulation only involves an
established body of technical regulations for which frequent and
routine amendments are necessary to keep them operationally current.
It, therefore: (1) Is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979);
and (3) does not warrant preparation of a regulatory evaluation as the
anticipated impact is so minimal. Since this is a routine matter that
only affects air traffic procedures and air navigation, it is certified
that this rule, when promulgated, does not have a significant economic
impact on a substantial number of small entities under the criteria of
the Regulatory Flexibility Act.

Environmental Review

    The FAA has determined that this action qualifies for categorical
exclusion under the National Environmental Policy Act in accordance
with FAA Order 1050.1F, ``Environmental Impacts: Policies and
Procedures,'' paragraph 5-6.5a. This airspace action is not expected to
cause any potentially significant environmental impacts, and no
extraordinary circumstances exist that warrant preparation of an
environmental assessment.

List of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

Adoption of the Amendment

    In consideration of the foregoing, the Federal Aviation
Administration amends 14 CFR part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for Part 71 continues to read as follows:

    Authority: 49 U.S.C. 106(f), 106(g); 40103, 40113, 40120, E.O.
10854, 24 FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR 71.1 of FAA Order 7400.11A,
Airspace Designations and Reporting Points, dated August 3, 2016,
effective September 15, 2016, is amended as follows:

Paragraph 5000 Class D Airspace.

* * * * *

AEA NY D Elmira, NY [Amended]

Elmira/Corning Regional Airport, NY
    (Lat. 42[deg]09'35'' N., long 76[deg]53'30'' W.)

    That airspace extending upward from the surface to and including
3,500 MSL within a 4.2-mile radius of the Elmira/Corning Regional
Airport. This Class D airspace area is effective during the specific
dates and times established in advance by a Notice to Airmen. The
effective date and time will thereafter be continuously published in
the Chart Supplement, (previously called Airport/Facility
Directory).

Paragraph 6002 Class E Surface Area Airspace.

* * * * *

AEA NY E2 Elmira, NY [Amended]

Elmira/Corning Regional Airport, NY
    (Lat. 42[deg]09'35'' N., long 76[deg]53'30'' W.)

    That airspace extending upward from the surface within a 4.2-
mile radius of the Elmira/Corning Regional Airport. This Class

E airspace area is effective during the specific dates and times
established in advance by a Notice to Airmen. The effective date and
time will thereafter be continuously published in the Chart
Supplement, (previously called Airport/Facility Directory).

Paragraph 6004 Class E Airspace Designated as an Extension to a
Class D Surface Area.

* * * * *

AEA NY E4 Elmira, NY [Amended]

Elmira/Corning Regional Airport, NY
    (Lat. 42[deg]09'35'' N., long 76[deg]53'30'' W.)

    That airspace extending upward from the surface within 1.8 miles
each side of the 062[deg] bearing from the airport extending from
the 4.2-mile radius of Elmira/Corning Regional Airport to 8.6-miles
northeast of the airport, within 1.8 miles each side of the 101[deg]
bearing from the airport extending from the 4.2-mile radius to 6
miles east of the airport, and within 1.8 miles each side of the
240[deg] bearing from the airport extending from the 4.2-mile radius
to 7 miles southwest of the airport, and within 1.8 miles each side
of the 282[deg] bearing from the airport extending from the 4.2-mile
radius to 8 miles northwest of the airport.

    Issued in College Park, Georgia, on February 23, 2017.
Ryan W. Almasy,
Manager, Operations Support Group, Eastern Service Center, Air Traffic
Organization.
[FR Doc. 2017-05802 Filed 3-24-17; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 78, Number 103 (Wednesday, May 29, 2013)]
[Rules and Regulations]
[Pages 32086-32087]
[FR Doc No: 2013-12623]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 71

[Docket No. FAA-2013-0147; Airspace Docket No. 13-AWP-1]

Establishment of Class E Airspace; Tuba City, AZ

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This action establishes Class E airspace at the Tuba City VHF
Omni-Directional Radio Range Tactical Air Navigational Aid (VORTAC),
Tuba City, AZ, to facilitate vectoring of Instrument Flight Rules (IFR)
aircraft under control of Denver, Albuquerque and Salt Lake City Air
Route Traffic Control Centers (ARTCCs). This improves the safety and
management of IFR operations in the vicinity of the VORTAC.

DATES: Effective date, 0901 UTC, August 22, 2013. The Director of the
Federal Register approves this incorporation by reference action under
1 CFR part 51, subject to the annual revision of FAA Order 7400.9 and
publication of conforming amendments.

FOR FURTHER INFORMATION CONTACT: Eldon Taylor, Federal Aviation
Administration, Operations Support Group, Western Service Center, 1601
Lind Avenue SW., Renton, WA, 98057; telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

History

    On March 19, 2013, the FAA published in the Federal Register a
notice of proposed rulemaking (NPRM) to amend controlled airspace at
Tuba City, AZ (78 FR 16823). Interested parties were invited to
participate in this rulemaking effort by submitting written comments on
the proposal to the FAA. No comments were received.
    Class E airspace designations are published in paragraph 6006, of
FAA Order 7400.9W dated August 8, 2012, and effective September 15,
2012, which is incorporated by reference in 14 CFR 71.1. The Class E
airspace designations listed in this document will be published
subsequently in that Order.

The Rule

    This action amends Title 14 Code of Federal Regulations (14 CFR)
part 71 by establishing Class E en route domestic airspace extending
upward from 1,200 feet above the surface, at the Tuba City VORTAC, Tuba
City, AZ. This action aids in containing aircraft while in IFR
conditions under control of Denver, Albuquerque and Salt Lake City
ARTCCs by vectoring aircraft from en route airspace to terminal areas.
    The FAA has determined this regulation only involves an established
body of technical regulations for which frequent and routine amendments
are necessary to keep them operationally current. Therefore, this
regulation: (1) Is not a ``significant regulatory action'' under
Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979);
and (3) does not warrant preparation of a regulatory evaluation as the
anticipated impact is so minimal. Since this is a routine matter that
only affects air traffic procedures and air navigation, it is certified
this rule, when promulgated, does not have a significant economic
impact on a substantial number of small entities under the criteria of
the Regulatory Flexibility Act. The FAA's authority to issue rules
regarding aviation safety is found in Title 49 of the U.S. Code.
Subtitle 1, Section 106 discusses the authority of the FAA
Administrator. Subtitle VII, Aviation Programs, describes in more
detail the scope of the agency's authority. This rulemaking is
promulgated under the authority described in Subtitle VII, Part A,
Subpart I, Section 40103. Under that section, the FAA is charged with
prescribing regulations to assign the use of airspace necessary to
ensure the safety of aircraft and the efficient use of airspace. This
regulation is within the scope of that authority as it establishes
controlled airspace at Tuba City, AZ.

Environmental Review

    The FAA has determined that this action qualifies for categorical
exclusion under the National Environmental Policy Act in accordance
with FAA Order 1050.1E, ``Environmental Impacts: Policies and
Procedures,'' paragraph 311a. This airspace action is not expected to
cause any potentially significant environmental impacts, and no
extraordinary circumstances exist that warrant preparation of an
environmental assessment.

List of Subjects in 14 CFR Part 71

    Airspace, Incorporation by reference, Navigation (air).

Adoption of the Amendment

    In consideration of the foregoing, the Federal Aviation
Administration amends 14 CFR part 71 as follows:

PART 71--DESIGNATION OF CLASS A, B, C, D AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND REPORTING POINTS

0
1. The authority citation for 14 CFR part 71 continues to read as
follows:

    Authority: 49 U.S.C. 106(g), 40103, 40113, 40120; E.O. 10854, 24
FR 9565, 3 CFR, 1959-1963 Comp., p. 389.

Sec.  71.1  [Amended]

0
2. The incorporation by reference in 14 CFR 71.1 of the Federal
Aviation Administration Order 7400.9W, Airspace Designations and
Reporting Points, dated August 8, 2012, and effective September 15,
2012 is amended as follows:

Paragraph 6006 En Route Domestic Airspace Areas.

* * * * *

ANM AZ E6 Tuba City, AZ [New]

Tuba City VORTAC, AZ
    (Lat. 36[deg]07'17'' N., long. 111[deg]16'11'' W.)

    That airspace extending upward from 1,200 feet above the surface
within an area bounded by lat. 39[deg]37'44'' N., long.
111[deg]07'28'' W.; to lat. 39[deg]26'10'' N., long. 110[deg]01'33''
W.; to lat. 38[deg]36'14'' N., long. 109[deg]28'14'' W.; to lat.
38[deg]35'57'' N., long. 109[deg]02'31'' W.; to lat. 38[deg]28'30''
N., long. 109[deg]03'18'' W.; to lat. 38[deg]04'06'' N., long.
108[deg]53'29'' W.; to lat. 37[deg]48'47'' N., long. 108[deg]54'40''
W.; to lat. 37[deg]37'12'' N., long. 109[deg]18'38'' W.; to lat.
37[deg]36'54'' N., long. 109[deg]35'55'' W.; to lat. 37[deg]04'41''
N., long. 109[deg]38'16'' W.; to lat. 36[deg]57'10'' N., long.
108[deg]55'03'' W.; to lat. 36[deg]36'32'' N., long. 108[deg]55'03''
W.; to lat. 36[deg]20'35'' N., long. 108[deg]47'12'' W.; to lat.
36[deg]05'15'' N., long. 108[deg]22'51'' W.; to lat. 36[deg]14'38''
N., long. 107[deg]40'25'' W.; to lat. 35[deg]39'30'' N., long.
107[deg]25'27'' W.; to lat. 35[deg]11'08'' N., long. 110[deg]03'48''
W.; to lat. 35[deg]16'08'' N., long. 111[deg]55'46'' W.; to lat.
35[deg]24'00'' N., long. 112[deg]00'00'' W.; to lat. 35[deg]46'00''
N., long. 111[deg]50'30'' W.; to lat. 36[deg]25'15'' N., long.
111[deg]30'15'' W.; to lat. 36[deg]44'00'' N., long. 111[deg]36'30''
W.; to lat. 37[deg]24'45'' N., long. 111[deg]52'45'' W.; to lat.
37[deg]30'00'' N., long. 112[deg]03'30'' W.; to lat. 37[deg]50'39''
N., long. 112[deg]24'51'' W.; to lat. 38[deg]10'56'' N., long.
111[deg]24'19'' W.; to lat. 38[deg]28'51'' N., long. 110[deg]38'05''
W.; to lat. 39[deg]03'55'' N., long. 110[deg]37'49'' W.; thence to
the point of beginning.

    Issued in Seattle, Washington, on May 15, 2013.
Clark Desing,
Manager, Operations Support Group, Western Service Center.
[FR Doc. 2013-12623 Filed 5-28-13; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register: March 13, 2009 (Volume 74, Number 48)]
[Notices]
[Page 10983-10984]
[DOCID:fr13mr09-117]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

[Docket No. FRA-2009-0016]

Metrics and Standards for Intercity Passenger Rail Service Under
Section 207 of Public Law 110-432

AGENCY: Federal Railroad Administration (FRA), Department of
Transportation (DOT).

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In compliance with section 207 of the Passenger Rail
Investment and Improvement Act of 2008 (Division B of Pub. L. 110-432),
the FRA and the National Railroad Passenger Corporation (Amtrak) have
jointly drafted performance metrics and standards for intercity
passenger rail service, and are requesting comments on that draft from
the Surface Transportation Board, rail carriers over whose rail lines
Amtrak trains operate, States, Amtrak employees, nonprofit employee
organizations representing Amtrak employees, and groups representing
Amtrak passengers. The draft document, entitled ``Proposed Metrics and
Standards for Intercity Passenger Rail Service,'' is available on the
FRA's Web site at http://www.fra.dot.gov/us/content/2165. Comments may
be submitted to the corresponding docket (number FRA-2009-0016) at
regulations.gov and will be considered before the finalized Section 207
metrics and standards are adopted.

DATES: The comment period will commence on Friday, March 13, 2009 and
Comments must be received by Friday, March 27, 2009. Comments received
after that date will be considered to the extent possible without
incurring additional expenses or delays.

ADDRESSES: Comments for Docket No. FRA-2009-0016 should be filed at the
Federal portal http://www.regulations.gov. Follow the Web site's online
instructions for submitting comments.

FOR FURTHER INFORMATION CONTACT: Neil E. Moyer, Chief, Intercity
Passenger Rail Analysis Division, U.S. Department of Transportation,
Federal Railroad Administration (e-mail<EMAIL_ADDRESS>telephone
202-493-6365); or Ed Courtemanch, Sr. Principal, Operations Service
Planning, Amtrak (e-mail<EMAIL_ADDRESS>telephone<PHONE_NUMBER>).

    Issued in Washington, DC, on March 9, 2009.
Neil Moyer,
Chief, Intercity Passenger Rail Analysis Division.
 [FR Doc. E9-5513 Filed 3-12-09; 8:45 am]

BILLING CODE 4910-06-P


[Federal Register Volume 84, Number 70 (Thursday, April 11, 2019)]
[Notices]
[Pages 14703-14704]
[FR Doc No: 2019-07144]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-85531; File No. SR-NYSEAMER-2018-39]

Self-Regulatory Organizations; NYSE American LLC; Notice of
Designation of Longer Period for Commission Action on Proceedings To
Determine Whether To Approve or Disapprove a Proposed Rule Change, as
Modified by Amendment No. 2, To Allow Flexible Exchange Equity Options
To Be Cash Settled Where the Underlying Security Is a Specified
Exchange-Traded Fund

April 5, 2019.
    On September 20, 2018, NYSE American LLC (``NYSE American'' or the
``Exchange'') filed with the Securities and Exchange Commission
(``Commission''), pursuant to Section 19(b)(1) of the Securities
Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder,\2\ a
proposed rule change to modify the rules related to Flexible Exchange
(``FLEX'') Options to allow cash settlement for certain FLEX Equity
Options. The proposal, as modified by Amendment No. 2, would allow FLEX
Equity Options to be cash settled where the underlying security is one
of 25 specified Exchange-Traded Funds.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

    The proposed rule change was published for comment in the Federal
Register on October 11, 2018.\3\ On November 19, 2018, pursuant to
Section 19(b)(2) of the Act,\4\ the Commission designated a longer
period within which to either approve the proposed rule change,
disapprove the proposed rule change, or institute proceedings to
determine whether to disapprove the proposed rule change.\5\ The
Commission received one comment letter on the proposed rule change.\6\
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 84364 (October 4,
2018), 83 FR 51535 (October 11, 2018) (``Notice'').
    \4\ 15 U.S.C. 78s(b)(2).
    \5\ See Securities Exchange Act Release No. 84616 (November 19,
2018), 83 FR 60519 (November 26, 2018). The Commission designated
January 9, 2019, as the date by which it should approve, disapprove,
or institute proceedings to determine whether to disapprove the
proposed rule change.
    \6\ See Letter to Brent J. Fields, Secretary, Commission, from
Samara Cohen, Head of ETF Global Markets, BlackRock, dated November
27, 2018 (``BlackRock Letter'').
---------------------------------------------------------------------------

    On December 19, 2018, the Commission instituted proceedings under
Section 19(b)(2)(B) of the Act \7\ to determine whether to approve or
disapprove the proposed rule change.\8\ On March 11, 2019, the Exchange
filed Amendment No. 1 to the proposed rule change. On March 25, 2019,
the Exchange withdrew Amendment No. 1 and filed Amendment No. 2 to the
proposed rule change, which superseded and replaced the proposed rule
change in its entirety.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b)(2)(B).
    \8\ See Securities Exchange Act Release No. 84870 (December 19,
2018), 83 FR 66779 (December 27, 2018) (``Order Instituting
Proceedings'').
---------------------------------------------------------------------------

    Section 19(b)(2) of the Act \9\ provides that, after initiating
proceedings, the Commission shall issue an order approving or
disapproving the proposed rule change not later than 180 days after the
date of publication of notice of the filing of the proposed rule
change. The Commission may extend the period for issuing an order
approving or disapproving the proposed rule change, however, by not
more than 60 days if the Commission determines that a longer period is
appropriate and publishes the reasons for such determination. The
proposed rule change was published for notice and comment in the
Federal Register on October 11, 2018.\10\ The 180th day after
publication of the Notice is April 9, 2019. The Commission is extending
the time period for approving or disapproving the proposal for an
additional 60 days.
---------------------------------------------------------------------------

    \9\ 15 U.S.C. 78s(b)(2).
    \10\ See supra note 3.
---------------------------------------------------------------------------

    The Commission finds that it is appropriate to designate a longer
period within which to issue an order approving or disapproving the
proposed rule change so that it has sufficient time to consider the
proposed rule change, as modified by Amendment No. 2. Accordingly, the
Commission, pursuant to Section 19(b)(2) of the Act,\11\ designates
June 8, 2019, as the date by

which the Commission should either approve or disapprove the proposed
rule change (File No. SR-NYSEAMER-2018-39), as modified by Amendment
No. 2.
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78s(b)(2).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(57).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Deputy Secretary.
[FR Doc. 2019-07144 Filed 4-10-19; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 169 (Wednesday, August 31, 2016)]
[Notices]
[Pages 60005-60007]
[FR Doc No: 2016-20914]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-D-0545]

Revised Recommendations for Reducing the Risk of Zika Virus
Transmission by Blood and Blood Components; Guidance for Industry;
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a document entitled ``Revised Recommendations for
Reducing the Risk of Zika Virus Transmission by Blood and Blood
Components; Guidance for Industry.'' The guidance document is notifying
blood establishments that collect Whole Blood and blood components,
that FDA has determined Zika virus (ZIKV) to be a relevant transfusion-
transmitted infection (RTTI) and provides FDA's assessment. The
guidance also provides recommendations to reduce the risk of
transmission of ZIKV by Whole Blood and blood components. The guidance
applies to the collection of Whole Blood and blood components. The
guidance does not apply to the collection of Source Plasma. The
guidance supersedes the February 2016 document entitled,
``Recommendations for Donor Screening, Deferral, and Product Management
to Reduce the Risk of Transfusion-Transmission of Zika Virus: Guidance
for Industry'' (February 2016 guidance), and the March 2016 document
entitled, ``Questions and Answers Regarding `Recommendations for Donor
Screening, Deferral, and Product Management to Reduce the Risk of
Transfusion-Transmission of Zika Virus: Guidance for Industry' '' no
later than 12 weeks after the date of the issuance of this guidance.
Implementation of the guidance will be immediate for blood
establishments that collect Whole Blood and blood components in States
and territories with local transmission of ZIKV by mosquitos, and will
be phased in over 4 to 12 weeks in other States and territories using a
tiered, risk-based approach. Blood establishments should follow the
recommendations in the February 2016 guidance until the recommendations
in the guidance document have been fully implemented.

DATES: The Agency is soliciting public comment, but is implementing
this guidance immediately because the

Agency has determined that prior public participation is not feasible
or appropriate. Submit either electronic or written comments on Agency
guidances at any time.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2016-D-0545 for ``Revised Recommendations for Reducing the Risk of
Zika Virus; Guidance for Industry.'' Received comments will be placed
in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at http://www.regulations.gov or at
the Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
    Submit written requests for single copies of the guidance to the
Office of Communication, Outreach and Development, Center for Biologics
Evaluation and Research (CBER), Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 3128, Silver Spring, MD 20993-0002. Send
one self-addressed adhesive label to assist the office in processing
your requests. The guidance may also be obtained by mail by calling
CBER at 1-800-835-4709 or<PHONE_NUMBER>. See the SUPPLEMENTARY
INFORMATION section for electronic access to the guidance document.

FOR FURTHER INFORMATION CONTACT: Jonathan McKnight, Center for
Biologics Evaluation and Research, Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002,
240-402-7911.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a guidance entitled ``Revised
Recommendations for Reducing the Risk of Zika Virus Transmission by
Blood and Blood Components; Guidance for Industry.'' The guidance is
notifying blood establishments that collect Whole Blood and blood
components that FDA has determined ZIKV to be an RTTI under 21 CFR
630.3(h)(2) and provides FDA's assessment. The guidance provides
recommendations to reduce the risk of transmission of ZIKV by Whole
Blood and blood components. The guidance does not apply to the
collection of Source Plasma, which is used for further manufacture of
plasma-derived products. If, based upon the available scientific
evidence, the risk of ZIKV transmission by blood and blood components
significantly changes, FDA may update the recommendations as warranted.
In making this determination, FDA will consider available epidemiologic
and other scientific evidence.
    The guidance supersedes the February 2016 guidance entitled,
``Recommendations for Donor Screening, Deferral, and Product Management
to Reduce the Risk of Transfusion-Transmission of Zika Virus; Guidance
for Industry'' and the March 2016 guidance entitled, ``Questions and
Answers Regarding `Recommendations for Donor Screening, Deferral, and
Product Management to Reduce the Risk of Transfusion-Transmission of
Zika Virus: Guidance for Industry' '' no later than 12 weeks after the
date of the issuance of this guidance. Implementation of the guidance
will be immediate for blood establishments that collect Whole Blood and
blood components in States and territories with local transmission of
ZIKV by mosquitos, and will be phased in over 4 to 12 weeks in other
States and territories using a tiered, risk-based approach. Blood
establishments should follow the recommendations in the February 2016
guidance until they fully implement the recommendations in the guidance
document currently being issued.
    ZIKV is an arbovirus from the Flaviviridae family, genus
Flavivirus. It is transmitted to humans primarily by the Aedes aegypti
mosquito, but it may also be transmitted by the Aedes albopictus
mosquito.
    The global ZIKV epidemic expanded in the region of the Americas by
early

2015 when the first local transmission was reported in Brazil. Local
transmission of ZIKV has also been reported in areas outside of the
Americas, including the Pacific Islands of Samoa, American Samoa,
Marshall Islands and Tonga, and Cape Verde in Africa, and there are now
at least 50 countries and territories worldwide with active local
transmission of the virus.
    The first local transmission of ZIKV in the United States was
reported from Puerto Rico in December 2015, and soon thereafter local
transmission was also reported in American Samoa and the U.S. Virgin
Islands. In July 2016, the first cases of local transmission of ZIKV
occurring in the continental United States were reported from Miami-
Dade County in Florida. The possibility of further geographic spread of
ZIKV exists in regions where the Aedes aegypti, and possibly the Aedes
albopictus, mosquito is present. In January 2016, ZIKV disease was
added to the list of nationally notifiable conditions in the United
States as a subtype of Arboviral diseases.
    The most common ZIKV disease symptoms include fever, arthralgia,
maculopapular rash, and conjunctivitis. In addition, neurological
manifestations and congenital anomalies have been associated with ZIKV
disease outbreaks. ZIKV infection has been associated with Guillain-
Barr[eacute] syndrome. ZIKV infection during pregnancy is a cause of
microcephaly and other serious fetal brain anomalies. Other problems
have been detected in pregnancies and among fetuses and infants
infected with ZIKV before birth, such as miscarriage, stillbirth,
absent or poorly developed brain structures, defects of the eye,
hearing deficits, and impaired growth; however, the full clinical
spectrum of the effects of ZIKV infection during pregnancy is not yet
known.
    FDA has identified ZIKV as a transfusion-transmitted infection
under Sec.  630.3(l) and RTTI under Sec.  630.3(h)(2). This
determination is based on the severity of the disease, risk of
transfusion-transmission by blood and blood components, the
availability of appropriate screening measures, and significant
incidence and prevalence affecting the potential donor population.
    The guidance recommends that blood establishments test all
donations collected in the United States and its territories with an
investigational individual donor nucleic acid test (ID-NAT) for ZIKV
under an investigational new drug application (IND), or when available,
a licensed test. Alternatively, blood establishments may implement
pathogen reduction technology for platelets and plasma using an FDA-
approved pathogen reduction device as specified in the Instructions for
Use of the device. If an FDA-approved pathogen reduction device becomes
available for Whole Blood or red blood cells, blood establishments may
implement pathogen reduction technology for such products rather than
testing the donations. Blood establishments implementing these measures
may discontinue providing donor educational material with respect to
ZIKV and screening donors for ZIKV risk factors such as travel history
and deferring them as previously recommended in the February 2016
guidance. Under 21 CFR 630.10(a), if a donor volunteers a recent
history of ZIKV infection, a blood establishment must not collect blood
or blood components from that donor. For such donors, the guidance
recommends a deferral period of 120 days after a positive viral test or
the resolution of symptoms, whichever timeframe is longer.
    FDA recommends that blood establishments implement the
recommendations in the guidance as follows: (1) Blood establishments
that collect Whole Blood and blood components in U.S. States and
territories with one or more reported locally acquired mosquito-borne
cases of ZIKV should implement the recommendations immediately. Blood
establishments should cease blood collection until testing or the use
of pathogen reduction technology is implemented, consistent with the
recommendations in the guidance. As of the date of issuance of the
guidance, the recommendations applies to blood establishments that
collect Whole Blood and blood components in Florida and Puerto Rico;
(2) because of their proximity to areas with locally acquired mosquito-
borne cases of ZIKV or because of other epidemiological linkage to
ZIKV, such as the number of travel-associated cases reported in a
State, blood establishments that collect Whole Blood and blood
components in Alabama, Arizona, California, Georgia, Hawaii, Louisiana,
Mississippi, New Mexico, New York, South Carolina, and Texas should
implement the recommendations as soon as feasible, but not later than 4
weeks after the guidance issue date; and (3) blood establishments that
collect Whole Blood and blood components in all other States and
territories should implement the recommendations as soon as feasible,
but not later than 12 weeks after the date of the issuance of this
guidance.
    This guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). FDA is issuing this guidance for
immediate implementation in accordance with 21 CFR 10.115(g)(2) without
initially seeking prior comment because the Agency has determined that
prior public participation is not feasible or appropriate. The guidance
represents the current thinking of FDA on ``Revised Recommendations for
Reducing the Risk of Zika Virus Transmission by Blood and Blood
Components.'' It does not establish any rights for any person and is
not binding on FDA or the public. You can use an alternative approach
if it satisfies the requirements of the applicable statutes and
regulations.

II. Paperwork Reduction Act of 1995

    This guidance refers to previously approved collections of
information found in FDA regulations. These collections of information
are subject to review by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The
collections of information in 21 CFR 601.12 have been approved under
OMB control number 0910-0338; the collections of information in 21 CFR
606.100(b) and 606.160(b)(1) have been approved under OMB control
number 0910-0795; and the collections of information in 21 CFR 606.122
and 630.30 have been approved under OMB control number 0910-0116.

III. Electronic Access

    Persons with access to the Internet may obtain the guidance at
either http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm or http://www.regulations.gov.

    Dated: August 25, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-20914 Filed 8-30-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 4 (Friday, January 6, 2023)]
[Notices]
[Page 1069]
[FR Doc No: 2023-00019]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL OP-OFA-051]

Environmental Impact Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General
Information<PHONE_NUMBER> or https://www.epa.gov/nepa.

Weekly receipt of Environmental Impact Statements (EIS)
Filed December 23, 2022 10 a.m. EST Through December 30, 2022 10 a.m.
EST
Pursuant to 40 CFR 1506.9.

    Notice: Section 309(a) of the Clean Air Act requires that EPA make
public its comments on EISs issued by other Federal agencies. EPA's
comment letters on EISs are available at: https://cdxapps.epa.gov/cdx-enepa-II/public/action/eis/search.

EIS No. 20230000, Draft Supplement, USFS, AK, Mendenhall Glacier
Visitor Facility Improvements, Comment Period Ends: 02/21/2023,
Contact: Monique Nelson<PHONE_NUMBER>.
EIS No. 20230001, Draft, TxDOT, TX, I-35 Capital Express Central
Project, Comment Period Ends: 03/07/2023, Contact: Doug Booher 512-416-
2734.

    Dated: December 30, 2022.
Cindy S. Barger,
Director, NEPA Compliance Division, Office of Federal Activities.
[FR Doc. 2023-00019 Filed 1-5-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 135 (Monday, July 15, 2013)]
[Rules and Regulations]
[Page 42011]
[FR Doc No: 2013-16809]

-----------------------------------------------------------------------

 DEPARTMENT OF HOMELAND SECURITY

Coast Guard

33 CFR Part 117

[Docket No. USCG-2013-0601]

Drawbridge Operation Regulation; The Straights, Harkers Island,
NC

AGENCY: Coast Guard, DHS.

ACTION: Notice of deviation from drawbridge regulation.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard has issued a temporary deviation from the
operating schedule that governs the swing of the Route 70/Harkers
Island Bridge, across The Straights, mile 0.6, Harkers Island, NC. This
deviation is necessary to facilitate coupling repair on the Route 70/
Harkers Island Bridge. This temporary deviation allows the swing bridge
to remain in the closed to navigation position.

DATES: This deviation is effective from noon until 11:59 p.m. on August
5, 2013.

ADDRESSES: The docket for this deviation, [USCG-2013-0601] is available
at http://www.regulations.gov. Type the docket number in the ``SEARCH''
box and click ``SEARCH.'' Click on Open Docket Folder on the line
associated with this deviation. You may also visit the Docket
Management Facility in Room W12-140 on the ground floor of the
Department of Transportation West Building, 1200 New Jersey Avenue SE.,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.

FOR FURTHER INFORMATION CONTACT: If you have questions on this
temporary deviation, call or email Mr. Jim Rousseau, Bridge
Administration Branch Fifth District, Coast Guard; telephone 757-398-
6557, email<EMAIL_ADDRESS>If you have questions on
viewing the docket, call Barbara Hairston, Program Manager, Docket
Operations,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: The North Carolina Department of
Transportation, who owns and operates this swing-type bridge, has
requested a temporary deviation from the current operating regulations
set out in 33 CFR 117.5 to facilitate coupling repair.
    Under the regular operating schedule for the Route 70/Harkers
Island Bridge, across The Straights, mile 0.6, in Harkers Island, NC,
the draw must open promptly and fully for the passage of vessels when a
request or signal to open is given. The drawbridge has a vertical
clearance in the closed position to vessels of 14.2 feet, above mean
high water.
    Under this temporary deviation, the drawbridge will be maintained
in the closed to navigation position from noon to 11:59 p.m. on August
5, 2013; the bridge will operate under normal operating schedule at all
other times. The drawbridge normally opens on demand with several small
commercial and recreational vessels transiting a week. Emergency
openings cannot be provided. There are no alternate routes for vessels
transiting this section of The Straights, but vessels that require an
opening may proceed before noon and after midnight. Mariners able to
pass under the bridge in the closed position may do so at any time and
are advised to proceed with caution.
    The Straights is used by a variety of vessels including small
commercial and recreational vessels. The Coast Guard has carefully
coordinated the restrictions with these waterway users. The Coast Guard
will also inform additional waterway users through our Local and
Broadcast Notices to Mariners of the closure periods for the bridge so
that vessels can arrange their transits to minimize any impacts caused
by the temporary deviation.
    In accordance with 33 CFR 117.35(e), the drawbridge must return to
its regular operating schedule immediately at the end of the designated
time period. This deviation from the operating regulations is
authorized under 33 CFR 117.35.

    Dated: July 2, 2013.
Waverly W. Gregory, Jr.,
Bridge Program Manager, Fifth Coast Guard District.
[FR Doc. 2013-16809 Filed 7-12-13; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register: June 23, 2010 (Volume 75, Number 120)]
[Notices]
[Page 35853]
[DOCID:fr23jn10-134]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

Proposed Collection; Comment Request

Upon Written Request, Copies Available From: Securities and Exchange
Commission, Office of Investor Education and Advocacy, Washington, DC
20549-0213.

Extension:
    Rule 15Ba2-1 and Form MSD; SEC File No. 270-0088; OMB Control
No. 3235-0083.

    Notice is hereby given that pursuant to the Paperwork Reduction Act
of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange
Commission (``Commission'') is soliciting comments on the existing
collection of information provided for in Rule 15Ba2-1 (17 CFR
240.15Ba2-1) and Form MSD (17 CFR 249.1100), under the Securities and
Exchange Act of 1934 (15 U.S.C. 78a et seq.) (``Exchange Act''). The
Commission plans to submit this existing collection of information to
the Office of Management and Budget for extension and approval.
    Rule 15Ba2-1 provides that an application for registration with the
Commission by a bank municipal securities dealer must be filed on Form
MSD. The Commission uses the information contained in Form MSD to
determine whether bank municipal securities dealers meet the standards
for registration set forth in the Exchange Act, to develop a central
registry where members of the public may obtain information about
particular bank municipal securities dealers, and to develop
statistical information about bank municipal securities dealers.
    Based upon past submissions, the staff estimates that approximately
41 respondents will utilize this application procedure annually. The
staff estimates that the average number of hours necessary to comply
with the requirements of Rule 15Ba2-1 is 1.5 hours per respondent, for
a total burden of 61.5 hours. The average cost per hour is
approximately $67. Therefore, the total cost of compliance for the
respondents is approximately $4,120.
    Written comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the Commission, including whether the information
shall have practical utility; (b) the accuracy of the Commission's
estimate of the burden of the proposed collection of information; (c)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted in
writing within 60 days of this publication.
    Please direct your written comments to: Charles Boucher, Director/
Chief Information Officer, Securities and Exchange Commission, c/o
Shirley Martinson, 6432 General Green Way, Alexandria, VA 22312 or send
an e-mail to<EMAIL_ADDRESS>
     June 14, 2010.
Florence E. Harmon,
Deputy Secretary.
[FR Doc. 2010-15134 Filed 6-22-10; 8:45 am]
BILLING CODE 8010-01-P


[Federal Register Volume 88, Number 21 (Wednesday, February 1, 2023)]
[Notices]
[Page 6718]
[FR Doc No: 2023-02092]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP23-371-000.
    Applicants: Eastern Gas Transmission and Storage, Inc.
    Description: Sec.  4(d) Rate Filing: EGTS--January 26, 2023
Negotiated Rate Agreement to be effective 2/1/2023.
    Filed Date: 1/26/23.
    Accession Number: 20230126-5014.
    Comment Date: 5 p.m. ET 2/7/23.

    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.

Filings in Existing Proceedings

    Docket Numbers: RP21-441-008.
    Applicants: Florida Gas Transmission Company, LLC.
    Description: Compliance filing: RP21-441 Settlement-Aggregation of
Public Agencies RS FTS-WD and FTS-WD-2 to be effective 2/25/2023.
    Filed Date: 1/25/23.
    Accession Number: 20230125-5084.
    Comment Date: 5 p.m. ET 2/6/23.

    Any person desiring to protest in any the above proceedings must
file in accordance with Rule 211 of the Commission's Regulations (18
CFR 385.211) on or before 5:00 p.m. Eastern time on the specified
comment date.
    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: January 26, 2023.
Debbie-Anne A. Reese,
Deputy Secretary.
[FR Doc. 2023-02092 Filed 1-31-23; 8:45 am]
BILLING CODE 6717-01-P


<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Carcinogen category 1B (Table 3.1)/carcinogen category 2 (Table 3.2) listed in Appendix 2

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

29.

Substances which appear in Part 3 of Annex VI to Regulation (EC) No 1272/2008 classified as germ cell mutagen category 1A or 1B (Table 3.1) or mutagen category 1 or 2 (Table 3.2) and listed as follows:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Mutagen category 1A (Table 3.1)/mutagen category 1 (Table 3.2) listed in Appendix 3

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Mutagen category 1B (Table 3.1)/mutagen category 2 (Table 3.2) listed in Appendix 4

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

30.

Substances which appear in Part 3 of Annex VI to Regulation (EC) No 1272/2008 classified as toxic to reproduction category 1A or 1B (Table 3.1) or toxic to reproduction category 1 or 2 (Table 3.2) and listed as follows:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Reproductive toxicant category 1A adverse effects on sexual function and fertility or on development (Table 3.1) or reproductive toxicant category 1 with R60 (May impair fertility) or R61 (May cause harm to the unborn child) (Table 3.2) listed in Appendix 5

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Reproductive toxicant category 1B adverse effects on sexual function and fertility or on development (Table 3.1) or reproductive toxicant category 2 with R60 (May impair fertility) or R61 (May cause harm to the unborn child) (Table 3.2) listed in Appendix 6

Without prejudice to the other parts of this Annex the following shall apply to entries 28 to 30:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be placed on the market, or used,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as substances,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as constituents of other substances, or,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in mixtures,

for supply to the general public when the individual concentration in the substance or mixture is equal to or greater than:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

either the relevant specific concentration limit specified in Part 3 of Annex VI to Regulation (EC) No 1272/2008, or,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

the relevant concentration specified in Directive 1999/45/EC.

Without prejudice to the implementation of other Community provisions relating to the classification, packaging and labelling of substances and mixtures, suppliers shall ensure before the placing on the market that the packaging of such substances and mixtures is marked visibly, legibly and indelibly as follows:

“Restricted to professional users”.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

By way of derogation, paragraph 1 shall not apply to:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

medicinal or veterinary products as defined by Directive 2001/82/EC and Directive 2001/83/EC;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

cosmetic products as defined by Directive 76/768/EEC;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

the following fuels and oil products:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

motor fuels which are covered by Directive 98/70/EC,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

mineral oil products intended for use as fuel in mobile or fixed combustion plants,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

fuels sold in closed systems (e.g. liquid gas bottles);

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(d)

artists’ paints covered by Directive 1999/45/EC.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

31.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

Creosote; wash oil

CAS No 8001-58-9

EC No 232-287-5

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

Creosote oil; wash oil

CAS No 61789-28-4

EC No 263-047-8

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

Distillates (coal tar), naphthalene oils; naphthalene oil

CAS No 84650-04-4

EC No 283-484-8

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(d)

Creosote oil, acenaphthene fraction; wash oil

CAS No 90640-84-9

EC No 283-484-8EC No 292-605-3

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(e)

Distillates (coal tar), upper; heavy anthracene oil

CAS No 65996-91-0

EC No 266-026-1

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(f)

Anthracene oil

CAS No 90640-80-5

EC No 292-602-7

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(g)

Tar acids, coal, crude; crude phenols

CAS No 65996-85-2

EC No 266-019-3

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(h)

Creosote, wood

CAS No 8021-39-4

EC No 232-419-1

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(i)

Low temperature tar oil, alkaline; extract residues (coal), low temperature coal tar alkaline

CAS No 122384-78-5

EC No 310-191-5

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be placed on the market, or used, as substances or in mixtures where the substance or mixture is intended for the treatment of wood. Furthermore, wood so treated shall not be placed on the market.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

By way of derogation from paragraph 1:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

The substances and mixtures may be used for wood treatment in industrial installations or by professionals covered by Community legislation on the protection of workers for in situ retreatment only if they contain:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(i)

benzo[a]pyrene at a concentration of less than 50 mg/kg (0,005 % by weight), and

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(ii)

water extractable phenols at a concentration of less than 3 % by weight.

Such substances and mixtures for use in wood treatment in industrial installations or by professionals:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

may be placed on the market only in packaging of a capacity equal to or greater than 20 litres,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

shall not be sold to consumers.

Without prejudice to the application of other Community provisions on the classification, packaging and labelling of substances and mixtures, suppliers shall ensure before the placing on the market that the packaging of such substances and mixtures is visibly, legibly and indelibly marked as follows:

“For use in industrial installations or professional treatment only”.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

Wood treated in industrial installations or by professionals according to subparagraph (a) which is placed on the market for the first time or retreated in situ may be used for professional and industrial use only, for example on railways, in electric power transmission and telecommunications, for fencing, for agricultural purposes (for example stakes for tree support) and in harbours and waterways.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

The prohibition in paragraph 1 on the placing on the market shall not apply to wood which has been treated with substances listed in entry 31 (a) to (i) before 31 December 2002 and is placed on the second-hand market for re-use.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

Treated wood referred to under paragraph 2(b) and (c) shall not be used:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

inside buildings, whatever their purpose,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in toys,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in playgrounds,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in parks, gardens, and outdoor recreational and leisure facilities where there is a risk of frequent skin contact,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in the manufacture of garden furniture such as picnic tables,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

for the manufacture and use and any re-treatment of:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

containers intended for growing purposes,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

packaging that may come into contact with raw materials, intermediate or finished products destined for human and/or animal consumption,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

other materials which may contaminate the articles mentioned above.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

32.

Chloroform

CAS No 67-66-3

EC No 200-663-8

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

34.

1,1,2-Trichloroethane

CAS No 79-00-5

EC No 201-166-9

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

35.

1,1,2,2-Tetrachloroethane

CAS No 79-34-5

EC No 201-197-8

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

36.

1,1,1,2-Tetrachloroethane

CAS No 630-20-6

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

37.

Pentachloroethane

CAS No 76-01-7

EC No 200-925-1

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

38.

1,1-Dichloroethene

CAS No 75-35-4

EC No 200-864-0

Without prejudice to the other parts of this Annex, the following shall apply to entries 32 to 38.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be placed on the market, or used,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as substances,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as constituents of other substances, or in mixtures in concentrations equal to or greater than 0,1 % by weight,

where the substance or mixture is intended for supply to the general public and/or is intended for diffusive applications such as in surface cleaning and cleaning of fabrics.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Without prejudice to the application of other Community provisions on the classification, packaging and labelling of substances and mixtures, suppliers shall ensure before the placing on the market that the packaging of such substances and mixtures containing them in concentrations equal to or greater than 0,1 % by weight is visibly, legibly and indelibly marked as follows:

“For use in industrial installations only”.

By way of derogation this provision shall not apply to:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

medicinal or veterinary products as defined by Directive 2001/82/EC and Directive 2001/83/EC;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

cosmetic products as defined by Directive 76/768/EEC.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

40.

Substances meeting the criteria of flammability in Directive 67/548/EEC and classified as flammable, highly flammable or extremely flammable regardless of whether they appear in Part 3 of Annex VI to Regulation (EC) No 1272/2008 or not.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be used, as substance or as mixtures in aerosol dispensers where these aerosol dispensers are intended for supply to the general public for entertainment and decorative purposes such as the following:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

metallic glitter intended mainly for decoration,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

artificial snow and frost,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

“whoopee” cushions,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

silly string aerosols,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

imitation excrement,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

horns for parties,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

decorative flakes and foams,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

artificial cobwebs,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

stink bombs.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Without prejudice to the application of other Community provisions on the classification, packaging and labelling of substances, suppliers shall ensure before the placing on the market that the packaging of aerosol dispensers referred to above is marked visibly, legibly and indelibly with:

“For professional users only”.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

By way of derogation, paragraphs 1 and 2 shall not apply to the aerosol dispensers referred to Article 8 (1a) of Council Directive 75/324/EEC (2).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

4.

The aerosol dispensers referred to in paragraphs 1 and 2 shall not be placed on the market unless they conform to the requirements indicated.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

41.

Hexachloroethane

CAS No 67-72-1

EC No 200-666-4

Shall not be placed on the market, or used, as substance or in mixtures, where the substance or mixture is intended for the manufacturing or processing of non-ferrous metals.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

42.

Alkanes, C10-C13, chloro (short-chain chlorinated paraffins) (SCCPs)

EC No 287-476-5

CAS No 85535-84-8

Shall not be placed on the market, or used as substances, or as constituents of other substances or in mixtures in concentrations greater than 1 % by weight, where the substance or mixture is intended for:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

metalworking,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

fat liquoring of leather.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

43.

Azocolourants and Azodyes

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Azodyes which, by reductive cleavage of one or more azo groups, may release one or more of the aromatic amines listed in Appendix 8, in detectable concentrations, i.e. above 30 mg/kg (0,003 % by weight) in the articles or in the dyed parts thereof, according to the testing methods listed in Appendix 10, shall not be used, in textile and leather articles which may come into direct and prolonged contact with the human skin or oral cavity, such as:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

clothing, bedding, towels, hairpieces, wigs, hats, nappies and other sanitary items, sleeping bags,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

footwear, gloves, wristwatch straps, handbags, purses/wallets, briefcases, chair covers, purses worn round the neck,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

textile or leather toys and toys which include textile or leather garments,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

yarn and fabrics intended for use by the final consumer.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Furthermore, the textile and leather articles referred to in paragraph 1 shall not be placed on the market unless they conform to the requirements set out in that paragraph.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

Azodyes, which are contained in Appendix 9, “List of azodyes” shall not be placed on the market, or used, as substances, or in mixtures in concentrations greater than 0,1 % by weight, where the substance or the mixture is intended for colouring textile and leather articles.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

44.

Diphenylether, pentabromo derivative

C12H5Br5O

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be placed on the market, or used,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as a substance,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in mixtures in concentrations greater than 0,1 % by weight.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Articles shall not be placed on the market if they, or flame-retarded parts thereof, contain this substance in concentrations greater than 0,1 % by weight.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

By way of derogation, paragraph 2 shall not apply

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

to articles that were in use in the Community before 15 August 2004,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

to electrical and electronic equipment within the scope of Directive 2002/95/EC of the European Parliament and Council (3).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

45.

Diphenylether, octabromo derivative

C12H2Br8O

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be placed on the market, or used:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as a substance,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as a constituent of other substances, or in mixtures, in concentrations greater than 0,1 % by weight.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Articles shall not be placed on the market if they, or flame-retardant parts thereof, contain this substance in concentrations greater than 0,1 % by weight.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

By way of derogation, paragraph 2 shall not apply:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

to articles that were in use in the Community before 15 August 2004,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

to electrical and electronic equipment within the scope of Directive 2002/95/EC.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

46.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

Nonylphenol

C6H4(OH)C9H19

CAS 25154-52-3

EC 246-672-0

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

Nonylphenol ethoxylates

(C2H4O)nC15H24O

Shall not be placed on the market, or used, as substances or in mixtures in concentrations equal to or greater than 0,1 % by weight for the following purposes:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(1)

industrial and institutional cleaning except:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

controlled closed dry cleaning systems where the washing liquid is recycled or incinerated,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

cleaning systems with special treatment where the washing liquid is recycled or incinerated.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(2)

domestic cleaning;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(3)

textiles and leather processing except:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

processing with no release into waste water,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

systems with special treatment where the process water is pre-treated to remove the organic fraction completely prior to biological waste water treatment (degreasing of sheepskin);

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(4)

emulsifier in agricultural teat dips;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(5)

metal working except:

uses in controlled closed systems where the washing liquid is recycled or incinerated;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(6)

manufacturing of pulp and paper;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(7)

cosmetic products;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(8)

other personal care products except:

spermicides;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(9)

co-formulants in pesticides and biocides. However national authorisations for pesticides or biocidal products containing nonylphenol ethoxylates as co-formulant, granted before 17 July 2003, shall not be affected by this restriction until their date of expiry.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

47.

Chromium VI compounds

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Cement and cement-containing mixtures shall not be placed on the market, or used, if they contain, when hydrated, more than 2 mg/kg (0,0002 %) soluble chromium VI of the total dry weight of the cement.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

If reducing agents are used, then without prejudice to the application of other Community provisions on the classification, packaging and labelling of substances and mixtures, suppliers shall ensure before the placing on the market that the packaging of cement or cement-containing mixtures is visibly, legibly and indelibly marked with information on the packing date, as well as on the storage conditions and the storage period appropriate to maintaining the activity of the reducing agent and to keeping the content of soluble chromium VI below the limit indicated in paragraph 1.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

By way of derogation, paragraphs 1 and 2 shall not apply to the placing on the market for, and use in, controlled closed and totally automated processes in which cement and cement-containing mixtures are handled solely by machines and in which there is no possibility of contact with the skin.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

48.

Toluene

CAS No 108-88-3

EC No 203-625-9

Shall not be placed on the market, or used, as a substance or in mixtures in a concentration equal to or greater than 0,1 % by weight where the substance or mixture is used in adhesives or spray paints intended for supply to the general public.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

49.

Trichlorobenzene

CAS No 120-82-1

EC No 204-428-0

Shall not be placed on the market, or used, as a substance or in mixtures in a concentration equal to or greater than 0,1 % by weight for any use except:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as an intermediate of synthesis, or,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

as a process solvent in closed chemical applications for chlorination reactions, or,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

in the manufacture of 1,3,5-triamino — 2,4,6-trinitrobenzene (TATB).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

50.

Polycyclic-aromatic hydrocarbons (PAH)

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

Benzo[a]pyrene (BaP)

CAS No 50-32-8

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

Benzo[e]pyrene (BeP)

CAS No 192-97-2

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

Benzo[a]anthracene (BaA)

CAS No 56-55-3

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(d)

Chrysen (CHR)

CAS No 218-01-9

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(e)

Benzo[b]fluoranthene (BbFA)

CAS No 205-99-2

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(f)

Benzo[j]fluoranthene (BjFA)

CAS No 205-82-3

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(g)

Benzo[k]fluoranthene (BkFA)

CAS No 207-08-9

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(h)

Dibenzo[a,h]anthracene (DBAhA)

CAS No 53-70-3

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

From 1 January 2010, extender oils shall not be placed on the market, or used for the production of tyres or parts of tyres if they contain:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

more than 1 mg/kg (0,0001 % by weight) BaP, or,

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

more than 10 mg/kg (0,001 % by weight) of the sum of all listed PAHs.

These limits shall be regarded as kept, if the polycyclic aromatics (PCA) extract is less than 3 % by weight as measured by the Institute of Petroleum standard IP346: 1998 (Determination of PCA in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method), provided that compliance with the limit values of BaP and of the listed PAHs, as well as the correlation of the measured values with the PCA extract, is controlled by the manufacturer or importer every six months or after each major operational change, whichever is earlier.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Furthermore, tyres and treads for retreading manufactured after 1 January 2010 shall not be placed on the market if they contain extender oils exceeding the limits indicated in paragraph 1.

These limits shall be regarded as kept, if the vulcanised rubber compounds do not exceed the limit of 0,35 % Bay protons as measured and calculated by ISO 21461 (Rubber vulcanised — Determination of aromaticity of oil in vulcanised rubber compounds).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

By way of derogation, paragraph 2 shall not apply to retreaded tyres if their tread does not contain extender oils exceeding the limits referred to in paragraph 1.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

4.

For the purpose of this entry “tyres” shall mean tyres for vehicles covered by:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Directive 2007/46/EC of the European Parliament and of the Council of 5 September 2007 establishing a framework for the approval of motor vehicles and their trailers (4),

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Directive 2003/37/EC of the European Parliament and of the Council of 26 May 2003 on type-approval of agricultural or forestry tractors, their trailers and interchangeable towed machinery, together with their systems, components and separate technical units (5), and

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

—

Directive 2002/24/EC of the European Parliament and of the Council of 18 March 2002 relating to the type-approval of two or three-wheel motor vehicles and repealing Council Directive 92/61/EEC (6).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

51.

The following phthalates (or other CAS and EC numbers covering the substance):

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

Bis (2-ethylhexyl) phthalate (DEHP)

CAS No 117-81-7

EC No 204-211-0

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

Dibutyl phthalate (DBP)

CAS No 84-74-2

EC No 201-557-4

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

Benzyl butyl phthalate (BBP)

CAS No 85-68-7

EC No 201-622-7

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be used as substances or in mixtures, in concentrations greater than 0,1 % by weight of the plasticised material, in toys and childcare articles.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Toys and childcare articles containing these phthalates in a concentration greater than 0,1 % by weight of the plasticised material shall not be placed on the market.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

The Commission shall re-evaluate, by 16 January 2010, the measures provided for in relation to this entry in the light of new scientific information on such substances and their substitutes, and if justified, these measures shall be modified accordingly.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

4.

For the purpose of this entry “childcare article” shall mean any product intended to facilitate sleep, relaxation, hygiene, the feeding of children or sucking on the part of children.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

52.

The following phthalates (or other CAS- and EC numbers covering the substance):

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

Di-“isononyl” phthalate (DINP)

CAS No 28553-12-0 and 68515-48-0

EC No 249-079-5 and 271-090-9

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

Di-“isodecyl” phthalate (DIDP)

CAS No 26761-40-0 and 68515-49-1

EC No 247-977-1 and 271-091-4

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

Di-n-octyl phthalate (DNOP)

CAS No 117-84-0

EC No 204-214-7

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be used as substances or in mixtures, in concentrations greater than 0,1 % by weight of the plasticised material, in toys and childcare articles which can be placed in the mouth by children.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Such toys and childcare articles containing these phthalates in a concentration greater than 0,1 % by weight of the plasticised material shall not be placed on the market.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

The Commission shall re-evaluate, by 16 January 2010, the measures provided for in relation to this entry in the light of new scientific information on such substances and their substitutes, and if justified, these measures shall be modified accordingly.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

4.

For the purpose of this entry “childcare article” shall mean any product intended to facilitate sleep, relaxation, hygiene, the feeding of children or sucking on the part of children.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

53.

Perfluorooctane sulfonates (PFOS) C8F17SO2X

(X = OH, Metal salt (O-M+), halide, amide, and other derivatives including polymers)

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

1.

Shall not be placed on the market, or used, as substances or in mixtures in concentrations equal to or greater than 50 mg/kg (0,005 % by weight).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

2.

Shall not be placed on the market in semi-finished products or articles, or parts thereof, if the concentration of PFOS is equal to or greater than 0,1 % by weight calculated with reference to the mass of structurally or microstructurally distinct parts that contain PFOS or, for textiles or other coated materials, if the amount of PFOS is equal to or greater than 1 μg/m2 of the coated material.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

3.

By way of derogation, paragraphs 1 and 2 shall not apply to the following items, nor to substances and mixtures needed to produce them:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

photoresists or anti-reflective coatings for photolithography processes;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

photographic coatings applied to films, papers, or printing plates;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

mist suppressants for non-decorative hard chromium (VI) plating and wetting agents for use in controlled electroplating systems where the amount of PFOS released into the environment is minimised, by fully applying relevant best available techniques developed within the framework of Directive 2008/1/EC (7);

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(d)

hydraulic fluids for aviation.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

4.

By way of derogation from paragraph 1, fire-fighting foams that were placed on the market before 27 December 2006 may be used until 27 June 2011.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

5.

By way of derogation, paragraph 2 shall not apply to articles that were in use in the Community before 27 June 2008.

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

6.

Paragraphs 1 and 2 shall apply without prejudice to Regulation (EC) No 648/2004 of the European Parliament and of the Council (8).

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

7.

As soon as new information on details of uses and safer alternative substances or technologies for the uses becomes available, the Commission shall review each of the derogations in paragraph 3(a) to (d) so that:

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(a)

the uses of PFOS will be phased out as soon as the use of safer alternatives is technically and economically feasible;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(b)

a derogation can only be continued for essential uses for which safer alternatives do not exist and where the efforts undertaken to find safer alternatives have been reported on;

<colgroup><col span="1" width="4%"><col span="1" width="96%"></colgroup>

(c)

releases of PFOS into the environment have been minimised, by applying best available techniques.


[Federal Register Volume 75, Number 11 (Tuesday, January 19, 2010)]
[Notices]
[Pages 2922-2923]
[FR Doc No: 2010-685]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Notice of Intent To Prepare an Environmental Assessment and
Request for Public Scoping Comments for the Air Tour Management Plan
Program at Death Valley National Park

AGENCY: Federal Aviation Administration (FAA).

ACTION: Notice of intent to prepare an Environmental Assessment and to
request Public Scoping comments.

-----------------------------------------------------------------------

SUMMARY: The FAA, with NPS as a cooperating agency, has initiated
development of an Air Tour Management Plan (ATMP) for Death Valley
National Park (DEVA), pursuant to the National Parks Air Tour
Management Act of 2000 (Public Law 106-181) and its implementing
regulations (14 CFR Part 136, Subpart B, National Parks Air Tour
Management). The objective of the ATMIP is to develop acceptable and
effective measures to mitigate or prevent the significant adverse
impacts, if any, of commercial air tour operations upon the natural
resources, cultural resources, and visitor experiences of a national
park unit and any tribal lands within or abutting the park. It should
be noted that the ATMP has no authorization over other non-air-tour
operations such as military and general aviation operations. In
compliance with the National Environmental Policy Act of 1969 (NEPA)
and FAA Order 1050.1E, an Environmental Assessment is being prepared.
    The ATMP will be prepared using an Aviation Rulemaking Committee
(ARC) process, as authorized under 49 U.S.C. 106. The purpose of using
the ARC process is to provide early advice, information, and
recommendations from interested stakeholders to the FAA and NPS,
regarding environmental and other issues to consider in the development
of an ATMP. The DEVA ARC is composed of various representatives
including air tour operators, federal, local and regional agencies,
environmental organizations, local businesses, and the Timbisha
Shoshone tribe. It is chaired by the Superintendent of Death Valley
National Park.
    In June 2009, the ARC held a two-day kickoff meeting at DEVA;
minutes may be found at: http://www.faa.gov/about/office_org/headquarters_offices/arc/programs/air_tourmanagement_plan/park_specific_plans/Death_Valley.cfm.
    The purpose of the kickoff meeting was for stakeholders to have the
opportunity to provide advice, information, and recommendations to the
FAA and NPS regarding environmental and other issues to consider in the
development of an ATMP. Materials presented at the meeting included
information on: Park resources; the acoustical environment at DEVA;
military operations over DEVA and the surrounding areas; current and
historical air tour operations; and, a map of current air tour flight
paths. Comments were received from members of the ARC regarding
sensitive park resources, tribal concerns, changes in tourism patterns,
and air tour operations. After a generalized map of current air tour
flight paths was presented, ARC members made suggestions regarding
options for an air tour flight track that would consolidate flight
paths and modify elevations and flight locations. ARC members'
recommendations attempted to address the concerns raised at the
meeting. Refer to the Public Scoping Document (mentioned below) to see
how these

suggestions are incorporated into an air tour route.
    Based on input received at the meeting, the FAA and NPS have
decided to proceed with ATMP development at DEVA via the ARC process.
The FAA is now inviting the public, agencies, and other interested
parties to provide comments, suggestions, and input on the scope of
issues and the identification of significant issues regarding
commercial air tours and their potential impacts on natural, cultural,
and historical resources. Input is also welcome on other areas to be
addressed in the environmental process, such as past, present, and
future actions (which, when considered with ATMIP alternatives, may
result in potentially significant cumulative impacts), and potential
ATMP alternatives.

DATES: By this notice, the FAA is requesting comments on the scope of
the environmental assessment for the ATMP at Death Valley National
Park. Comments must be submitted by February 18, 2010.

FOR FURTHER INFORMATION CONTACT: Keith Lusk--Mailing address: P.O. Box
92007, Los Angeles, California 90009-2007. Telephone:<PHONE_NUMBER>.
Street address: 15000 Aviation Boulevard, Lawndale, California 90261.
E-mail<EMAIL_ADDRESS>Written comments on the scope of the
Environmental Assessment should be submitted electronically via the
electronic public comment form on the NPS Planning, Environment and
Public Comment System at: http://parkplanning.nps.gov/projectHome.cfm?parkId=297&projectId=27781, or sent to the mailing
address or e-mail address above.

SUPPLEMENTARY INFORMATION: A Public Scoping Document that describes the
project in greater detail is available at:

 The NPS Planning, Environment and Public Comment System at:
http://parkplanning.nps.gov/projectHome.cfm?parkId=297&projectId=27781
 http://www.faa.gov/about/office_org/headquarters_offices/arc/programs/air_tourmanagement_plan/park_specific_plans/Death_Valley.cfm
 The following locations within Death Valley National Park:
Furnace Creek Visitor Center & Museum, Stovepipe Wells Ranger Station,
Scotty's Castle
 Shoshone Museum, Shoshone, CA
 Eastern Sierra Interagency Center, Highway 395 and Highway
136, Lone Pine, CA
 Beatty Library District, 400 North 4th Street, Beatty, NV
 Inyo County Free Library: 168 North Edwards Street,
Independence, CA; 210 Academy Street and 110 North Main Street in
Bishop, CA
 Pahrump Community Library: 701 East Street, Pahrump, NV
 Amargosa Valley Library: 829 East Farm Road, Amargosa Valley,
NV

    Notice Regarding FOIA: Individuals may request that their name and/
or address be withheld from public disclosure. If you wish to do this,
you must state this prominently at the beginning of your conmient.
Commentators using the Web site can make such a request by checking the
box ``keep my contact information private.'' Such requests will be
honored to the extent allowable by law, but you should be aware that
pursuant to the Freedom of Information Act, your name and address may
be disclosed. We will make all submissions from organizations,
businesses, and from individuals identifying themselves as
representatives or officials of organizations or businesses available
for public inspection in their entirety.

    Issued in Hawthorne, CA, on January 7, 2010.
Barry Brayer,
Manager, Special Programs Staff, Western-Pacific Region.
[FR Doc. 2010-685 Filed 1-15-10; 8:45 am]
BILLING CODE M